Used in pharmaceutical research as a key intermediate in the synthesis of dopamine receptor ligands. Shows potential in the development of treatments for neurological disorders such as Parkinson’s disease and schizophrenia. Its structure allows for high selectivity and binding affinity to D3 and D2 dopamine receptors, making it valuable in creating targeted therapies with fewer side effects. Also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties of central nervous system (CNS) drugs.